| Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment … JE Wagner, JN Barker, TE DeFor, KS Baker, BR Blazar, C Eide, ... Blood, The Journal of the American Society of Hematology 100 (5), 1611-1618, 2002 | 1366 | 2002 |
| Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems ML MacMillan, DJ Weisdorf, JE Wagner, TE DeFor, LJ Burns, ... Biology of blood and marrow transplantation 8 (7), 387-394, 2002 | 507 | 2002 |
| Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation SG Holtan, TE DeFor, A Lazaryan, N Bejanyan, M Arora, CG Brunstein, ... Blood, The Journal of the American Society of Hematology 125 (8), 1333-1338, 2015 | 477 | 2015 |
| Umbilical cord blood–derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect CG Brunstein, JS Miller, DH McKenna, KL Hippen, TE DeFor, D Sumstad, ... Blood, The Journal of the American Society of Hematology 127 (8), 1044-1051, 2016 | 436 | 2016 |
| Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units MR Verneris, CG Brunstein, J Barker, ML MacMillan, T DeFor, ... Blood, The Journal of the American Society of Hematology 114 (19), 4293-4299, 2009 | 337 | 2009 |
| Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord … ML Macmillan, BR Blazar, TE DeFor, JE Wagner Bone marrow transplantation 43 (6), 447-454, 2009 | 323 | 2009 |
| Nixon And Mao: the Week That Changed the World M MacMillan Random House, 2008 | 320 | 2008 |
| A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality ML MacMillan, M Robin, AC Harris, TE DeFor, PJ Martin, A Alousi, VT Ho, ... Biology of Blood and Marrow Transplantation 21 (4), 761-767, 2015 | 300 | 2015 |
| Generation and large-scale expansion of human inducible regulatory T cells that suppress graft-versus-host disease KL Hippen, SC Merkel, DK Schirm, C Nelson, NC Tennis, JL Riley, ... American Journal of Transplantation 11 (6), 1148-1157, 2011 | 278 | 2011 |
| Germline mutations in BRCA2: shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia JE Wagner, J Tolar, O Levran, T Scholl, A Deffenbaugh, J Satagopan, ... Blood 103 (8), 3226-3229, 2004 | 268 | 2004 |
| Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors ML MacMillan, DJ Weisdorf, CG Brunstein, Q Cao, TE DeFor, MR Verneris, ... Blood, The Journal of the American Society of Hematology 113 (11), 2410-2415, 2009 | 259 | 2009 |
| Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc … J Bolaños-Meade, R Reshef, R Fraser, M Fei, S Abhyankar, Z Al-Kadhimi, ... The Lancet Haematology 6 (3), e132-e143, 2019 | 258 | 2019 |
| Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trial SJ Lee, D Zahrieh, E Agura, ML MacMillan, RT Maziarz, PL McCarthy Jr, ... Blood 104 (5), 1559-1564, 2004 | 252 | 2004 |
| Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin’s lymphoma NS Majhail, DJ Weisdorf, TE Defor, JS Miller, PB McGlave, A Slungaard, ... Biology of Blood and Marrow Transplantation 12 (10), 1065-1072, 2006 | 246 | 2006 |
| Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT C Cutler, B Logan, R Nakamura, L Johnston, S Choi, D Porter, WJ Hogan, ... Blood, The Journal of the American Society of Hematology 124 (8), 1372-1377, 2014 | 244 | 2014 |
| Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia JE Wagner, M Eapen, ML MacMillan, RE Harris, R Pasquini, F Boulad, ... Blood 109 (5), 2256-2262, 2007 | 234 | 2007 |
| Successful hematopoietic stem cell transplantation for Fanconi anemia from an unaffected HLA-genotype–identical sibling selected using preimplantation genetic diagnosis SS Grewal, JP Kahn, ML MacMillan, NKC Ramsay, JE Wagner Blood 103 (3), 1147-1151, 2004 | 178 | 2004 |
| The best endpoint for acute GVHD treatment trials ML MacMillan, TE DeFor, DJ Weisdorf Blood, The Journal of the American Society of Hematology 115 (26), 5412-5417, 2010 | 177 | 2010 |
| Early antithymocyte globulin therapy improves survival in patients with steroid-resistant acute graft-versus-host disease ML MacMillan, DJ Weisdorf, SM Davies, TE DeFor, LJ Burns, ... Biology of Blood and Marrow Transplantation 8 (1), 40-46, 2002 | 174 | 2002 |
| Serious infections after unrelated donor transplantation in 136 children: impact of stem cell source JN Barker, RE Hough, JAH van Burik, TE DeFor, ML MacMillan, ... Biology of blood and marrow transplantation 11 (5), 362-370, 2005 | 151 | 2005 |
